Joel S Marcus has bought stock on 8 days since Oct 2014
Executive Chair at Alexandria Real Estate Equities, Inc., and 5 other companies
SEC CIK 0001216955 · Filings on SEC.gov ↗
Joel S Marcus's record
3 months after each buy, from the first price a copier could get.
3 buys since 2018 with 3 months of prices.
Companies
Every filing
76 filings since Mar 2016, newest first
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Executive Chair
ALEXANDRIA REAL ESTATE EQUITIES, INC.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Intra-Cellular Therapies, Inc.
Director
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Intra-Cellular Therapies, Inc.
Director
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Intra-Cellular Therapies, Inc.
Director
Intra-Cellular Therapies, Inc.
Director
Intra-Cellular Therapies, Inc.
Director
Intra-Cellular Therapies, Inc.
Director
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Intra-Cellular Therapies, Inc.
Director
Alexandria Real Estate Equities, Inc.
Executive Chair
Intra-Cellular Therapies, Inc.
Director
Frequency Therapeutics, Inc.
Director
Alexandria Real Estate Equities, Inc.
Executive Chair
Meiragtx Holdings Plc
Director
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Frequency Therapeutics, Inc.
Director
Frequency Therapeutics, Inc.
Director
Intra-Cellular Therapies, Inc.
Director
Applied Therapeutics Inc.
Director
Meiragtx Holdings Plc
Director
Intra-Cellular Therapies, Inc.
Director
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities, Inc.
Executive Chair
Alexandria Real Estate Equities Inc
Executive Chair
Applied Therapeutics Inc.
Director
Alexandria Real Estate Equities Inc
Executive Chair
Alexandria Real Estate Equities Inc
Executive Chair
Alexandria Real Estate Equities Inc
Executive Chair
Atara Biotherapeutics, Inc.
Director
Atara Biotherapeutics, Inc.
Director
Alexandria Real Estate Equities Inc
Executive Chair
Alexandria Real Estate Equities Inc
Executive Chair
Alexandria Real Estate Equities Inc
Executive Chair
About Joel S Marcus
Joel S. Marcus is the Executive Chairman and Founder of Alexandria Real Estate Equities, Inc. (NYSE: ARE), a pioneering S&P 500 real estate investment trust (REIT) focused on collaborative life science and technology campuses in AAA innovation cluster locations.( He co-founded the company in 1994 as a garage startup with $19 million in Series A capital, transforming it from a niche player into the preeminent owner, operator, and developer in the sector, with significant growth in market capitalization to approximately $36 billion by 2021 and an expansive portfolio across Greater Boston, San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle.(
Prior to April 2018, Marcus served as Chairman, CEO, and President of Alexandria, and he founded Alexandria Venture Investments in 1996, managing about $2 billion in strategic investments in seed-, early-, and growth-stage life science, agrifoodtech, and technology companies.( A JD and CPA, he previously worked as a partner at a law firm before launching Alexandria.( Marcus recently purchased 25,000 shares of ARE on February 12, 2026, as Executive Chairman.( He serves on boards including Applied Therapeutics Inc., Atara Biotherapeutics, and Intra-Cellular Therapies, Inc., and co-founded Accelerator Life Science Partners and AgTech Accelerator.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.